cbdMD, Inc. (YCBD) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 80 transactions totaling $6.4M, demonstrating a bearish sentiment with -$5.4M in net insider flow. The most recent transaction on Dec 17, 2025 involved a sale of 461,725 shares valued at $1.1M.
No significant insider buying has been recorded for YCBD in the recent period.
No significant insider selling has been recorded for YCBD in the recent period.
Based on recent SEC filings, insider sentiment for YCBD is bearish with an Insider Alignment Score of 8/100 and a net flow of -$5.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at cbdMD, Inc. (YCBD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading YCBD stock, having executed 80 transactions in the past 90 days. The most active insider is Martin A. Sumichrast (Executive), who has made 18 transactions totaling $4.1M.
Get notified when executives and directors at YCBD file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | R. Crosnoe Clark | Executive | Sale | 461,725 | $2.31 | $1.1M | Large |
| Dec 17, 2025 | R. Crosnoe Clark | Executive | Sale | 19,101 | $2.34 | $44.7K | |
| Dec 17, 2025 | R. Crosnoe Clark | Executive | Sale | 69,875 | $2.34 | $163.5K | |
| Nov 28, 2025 | Ronan Kennedy Thomas | Executive | Award | 445,000 | $N/A | $0 | |
| Aug 23, 2024 | F. Raines William III | Executive | Award | 75,000 | $N/A | $0 | |
| Mar 29, 2024 | T. Sellers Bakari | Executive | Award | 4,000 | $N/A | $0 | |
| Mar 29, 2024 | F. Raines William III | Executive | Award | 4,000 | $N/A | $0 | |
| Mar 29, 2024 | G. Stephen Scott | Executive | Award | 4,000 | $N/A | $0 | |
| Mar 29, 2024 | Nichole Swift Sibyl | Executive | Award | 4,000 | $N/A | $0 | |
| Jan 11, 2024 | Scott Coffman Raymond | Executive | Award | 13,011 | $N/A | $0 | |
| May 3, 2023 | Ronan Kennedy Thomas | Executive | Purchase | 5,000 | $2.10 | $10.5K | |
| Feb 17, 2023 | Nichole Swift Sibyl | Executive | Award | 5,000 | $N/A | $0 | |
| Feb 17, 2023 | G. Stephen Scott | Executive | Award | 5,000 | $N/A | $0 | |
| Feb 17, 2023 | T. Sellers Bakari | Executive | Award | 5,000 | $N/A | $0 | |
| Feb 17, 2023 | F. Raines William III | Executive | Award | 5,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 15 | $5.9M | 92.2% |
Purchase(P) | 13 | $504.6K | 7.8% |
Award(A) | 36 | $0 | 0.0% |
Exercise(M) | 2 | $0 | 0.0% |
Other(J) | 14 | $0 | 0.0% |
Insider selling pressure at cbdMD, Inc. has increased, with 16 insiders executing 80 transactions across all time. Total sales of $5.9M significantly outpace purchases of $504.6K, resulting in a net outflow of $5.4M. This selling activity appears largely discretionary, which may warrant closer attention from investors.